Interview with Yvonne Schallberger about the successful evaluation of the BÜHLMANN fPELA® turbo test at Bioanalytica in Lucerne.
- info@buhlmannlabs.ch
- +41 61 487 12 12
News
We are happy to announce the new Novaplex™ SARS-CoV-2 Variant VII Assay from Seegene, which will become available by the end of December 2021.
We received the notification from Seegene, in which they confirmed the detectability of Allplex™ assays with respect to the Omicron variant, B.1.1.529 of SARS-CoV-2, which has emerged in South Africa.
Interview with Dr. Cyril A. Fuhrer about the successful evaluation of the BÜHLMANN fPELA® turbo test at Synlab Suisse SA in Lucerne.
Social Links